Evidence map›Paper›PMID 41145629›Full record

ArticleScientific reports2025

Transfer learning on protein language models improves antimicrobial peptide classification.

Elias Georgoulis, Michaela Areti Zervou, Yannis Pantazis

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Elias GeorgoulisInstitute of Applied and Computational Mathematics, FORTH, Heraklion, 700 13, Greece.
Michaela Areti ZervouDepartment of Computer Science, University of Crete, Heraklion, 700 13, Greece.
Yannis PantazisInstitute of Applied and Computational Mathematics, FORTH, Heraklion, 700 13, Greece. pantazis@iacm.forth.gr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial peptides (AMPs) are essential components of the innate immune system in humans and other organisms, exhibiting potent activity against a broad spectrum of pathogens. Their potential therapeutic applications, particularly in combating antibiotic resistance, have rendered AMP classification a vital task in computational biology. However, the scarcity of labeled AMP sequences, coupled with the diversity and complexity of AMPs, poses significant challenges for the training of standalone AMP classifiers. Self-supervised learning has emerged as a powerful paradigm in addressing such challenges across various fields, leading to the development of Protein Language Models (PLMs). These models leverage vast amounts of unlabeled protein sequences to learn biologically relevant features, providing transferable protein sequence representations (embeddings), that can be fine-tuned for downstream tasks even with limited labeled data. This study evaluates the performance of several publicly-available PLMs in AMP classification utilizing transfer learning techniques and benchmarking them against state-of-the-art neural-based classifiers. Our key findings include: (a) Model scale is crucial, with classification performance consistently improving with increasing model size; (b) State-of-the-art results are achieved with minimal effort utilizing PLM embedding representations alongside shallow classifiers; and (c) Classification performance is further enhanced through efficient fine-tuning of PLMs' parameters. Code showcasing our pipelines is available at https://github.com/EliasGeorg/PLM_AMP_Classification .

Indexed as

Antimicrobial PeptidesComputational BiologyHumansMachine LearningAntimicrobial PeptidesAntimicrobial peptide classificationComputational protein engineeringLow-rank adaptationProtein language modelsTransfer learning

Identifiers

PMID41145629
PMCPMC12559171

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.